Cargando…

Sheathless CE-MS based metabolic profiling of kidney tissue section samples from a mouse model of Polycystic Kidney Disease

Capillary electrophoresis-mass spectrometry (CE-MS) using a sheathless porous tip interface emerged as an attractive tool in metabolomics thanks to its numerous advantages. One of the main advantages compared to the classical co-axial sheath liquid interface is the increased sensitivity, while maint...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sánchez-López, Elena, Kammeijer, Guinevere S. M., Crego, Antonio L., Marina, María Luisa, Ramautar, Rawi, Peters, Dorien J. M., Mayboroda, Oleg A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349881/ https://www.ncbi.nlm.nih.gov/pubmed/30692602 http://dx.doi.org/10.1038/s41598-018-37512-8

Ejemplares similares

Sheathless Capillary Electrophoresis–Mass Spectrometry for Metabolic Profiling of Biological Samples
por: Zhang, Wei, et al.
Publicado: (2016)

Site-Specific N-Linked Glycosylation Analysis of Human Carcinoembryonic Antigen by Sheathless Capillary Electrophoresis–Tandem Mass Spectrometry
por: Pont, Laura, et al.
Publicado: (2021)

Sheathless capillary electrophoresis‐mass spectrometry for anionic metabolic profiling
por: Gulersonmez, Mehmet Can, et al.
Publicado: (2015)

CE‐MS for metabolomics: Developments and applications in the period 2018–2020
por: Zhang, Wei, et al.
Publicado: (2020)

Urinary metabolites associate with the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease
por: Dekker, Shosha E. I., et al.
Publicado: (2020)

CE–MS for anionic metabolic profiling: An overview of methodological developments
por: van Mever, Marlien, et al.
Publicado: (2019)

CE–MS for metabolomics: Developments and applications in the period 2014–2016
por: Ramautar, Rawi, et al.
Publicado: (2016)

CE‐MS for metabolomics: Developments and applications in the period 2016–2018
por: Ramautar, Rawi, et al.
Publicado: (2018)

Highly sensitive CE-ESI-MS analysis of N-glycans from complex biological samples
por: Lageveen-Kammeijer, Guinevere S. M., et al.
Publicado: (2019)

Transcriptionally imprinted glycomic signatures of acute myeloid leukemia
por: Blöchl, Constantin, et al.
Publicado: (2023)

An Integrated Glycosylation Signature of Rheumatoid Arthritis
por: Mayboroda, Oleg A., et al.
Publicado: (2023)

Short salsalate administration affects cell proliferation, metabolism, and inflammation in polycystic kidney disease
por: Kanhai, Anish A., et al.
Publicado: (2023)

High Diversity of Glycosphingolipid Glycans of Colorectal Cancer Cell Lines Reflects the Cellular Differentiation Phenotype
por: Wang, Di, et al.
Publicado: (2022)

In-Depth Analysis of the N-Glycome of Colorectal Cancer Cell Lines
por: Wang, Di, et al.
Publicado: (2023)

Salsalate, but not metformin or canagliflozin, slows kidney cyst growth in an adult-onset mouse model of polycystic kidney disease
por: Leonhard, Wouter N., et al.
Publicado: (2019)

Sialic acid linkage differentiation of glycopeptides using capillary electrophoresis – electrospray ionization – mass spectrometry
por: Kammeijer, Guinevere S. M., et al.
Publicado: (2017)

Colorectal cancer cell lines show striking diversity of their O-glycome reflecting the cellular differentiation phenotype
por: Madunić, Katarina, et al.
Publicado: (2020)

Sheathless Size-Based Acoustic Particle Separation
por: Guldiken, Rasim, et al.
Publicado: (2012)

Sheathless Microflow Cytometry Using Viscoelastic Fluids
por: Asghari, Mohammad, et al.
Publicado: (2017)

The Use of a Sheathless Basket via Miniature Ureteroscopes
por: Watson, Graham
Publicado: (1995)

Polycystic horseshoe kidney
por: Prasad, A. K., et al.
Publicado: (2013)

Horseshoe polycystic kidney
por: Maple, Hannah, et al.
Publicado: (2013)

Polycystic horseshoe kidney
por: Ram, Rapur, et al.
Publicado: (2013)

Specific (sialyl-)Lewis core 2 O-glycans differentiate colorectal cancer from healthy colon epithelium
por: Madunić, Katarina, et al.
Publicado: (2022)

Urine Fetuin-A is a biomarker of autosomal dominant polycystic kidney disease progression
por: Piazzon, Nathalie, et al.
Publicado: (2015)

Polycystic Kidney Disease Caused by Bilineal Inheritance of Truncating PKD1 as Well as PKD2 Mutations
por: Losekoot, Monique, et al.
Publicado: (2020)

Understanding the Significance of Sample Preparation in Studies of the Nanoparticle Metabolite Corona
por: Zhang, Wei, et al.
Publicado: (2022)

Molecular genetic analysis of polycystic kidney disease 1 and polycystic kidney disease 2 mutations in pedigrees with autosomal dominant polycystic kidney disease
por: Bitarafan, Fatemeh, et al.
Publicado: (2019)

Deficiency of FLCN in Mouse Kidney Led to Development of Polycystic Kidneys and Renal Neoplasia
por: Chen, Jindong, et al.
Publicado: (2008)

Fistuloplasty using a radiation-and-time-saving sheathless balloon catheter
por: Crawford, Joel, et al.
Publicado: (2018)

Successful removal of entrapped Burr with sheathless guiding during stent rotablation
por: Ruzsa, Zoltán, et al.
Publicado: (2017)

Inadvertent Transmission of Polycystic Kidney Disease in Kidney Transplantation
por: Langote, Amit, et al.
Publicado: (2015)

Laparoscopic Nephrectomy for Massive Kidneys in Polycystic Kidney Disease
por: Collini, Andrea, et al.
Publicado: (2021)

Glycosphingolipid-Glycan Signatures of Acute Myeloid Leukemia Cell Lines Reflect Hematopoietic Differentiation
por: Wang, Di, et al.
Publicado: (2022)

Urinary Biomarkers to Identify Autosomal Dominant Polycystic Kidney Disease Patients With a High Likelihood of Disease Progression
por: Messchendorp, A. Lianne, et al.
Publicado: (2017)

Beyond polycystic kidney disease
por: Santos, Susana Franco, et al.
Publicado: (2017)

Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022)

Autosomal Recessive Polycystic Kidney Disease
por: Hafer, Ashley S., et al.
Publicado: (2017)

Evaluation of urine biomarkers of kidney injury in Polycystic Kidney Disease
por: Parikh, Chirag R., et al.
Publicado: (2012)

High-Throughput Phenotypic Screening of Kinase Inhibitors to Identify Drug Targets for Polycystic Kidney Disease
por: Booij, Tijmen H., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r8nnjnn0iqul10svqrllr6keqh